Case No. | Sex | Origin | Size (mm) | TLE1 (luminal cell) | β-catenin (abluminal cell) | Ki67 | Mitosis (/10HPF) | CTNNB1 mutation | Follow-up (Months) |
---|---|---|---|---|---|---|---|---|---|
1 | F | P | 11 | ++ | – | 3.4% | 1/10 | – | 6 |
2 | M | P | 20 | ++ | ++ | 1.1% | 1/10 | + | 6 |
3 | F | P | 10 | + | ++ | 1% | 1/10 | – | 2 |
4 | M | P | 20 | ++ | + | 1.3% | 0/10 | + | 6 |
5 | F | P | 16 | ++ | ++ | 1.1% | 0/10 | + | 25 |
6 | M | P | 30 | ++ | – | 1.9% | 1/10 | – | 32 |
7 | F | P | 30 | ++ | - (cytoplasm+) | 3% | 1/10 | – | 38 |
8 | F | P | 20 | ++ | ++ | 0.5% | 0/10 | – | 1 |
9 | M | P | 10 | ++ | ++ | 0.4% | 1/10 | – | 38 |
10 | M | P | 20 | ++ | + | 1.1% | 1/10 | + | 12 |
11 | F | P | 20 | + | – | 1.7% | 0/10 | – | 43 |
12 | M | P | 20 | ++ | ++ | 1.5% | 0/10 | – | 1 |
13 | F | P | 8 | + | + | 1.1% | 1/10 | – | 28 |
14 | F | P | 35 | – | – | 1.0% | 0/10 | – | 76 |
15 | F | P | 26 | + | ++ | 1.3% | 0/10 | – | 18 |
16 | M | S | 44 | + | – | 0.9% | 3/10 | – | 18 |
17 | F | P | 10 | ++ | ++ | 1.0% | 1/10 | + | 141 |
18 | F | P | 15 | + | + | 2.3% | 1/10 | – | 100 |
19 | F | P | 20 | + | ++ | 1.0% | 1/10 | – | 7 |
20 | F | P | 60 | + | + | 2.4% | 0/10 | + | 12 |
21 | F | P | 25 | + | ++ | 1.5% | 0/10 | + | 65 |
22 | M | P | 20 | - (old sample) | – | 1.0% | 0/10 | + | 43 |
23 | F | S | 10 | ++ | – | 1.7% | 0/10 | – | 4 |
24 | F | P | 20 | ++ | ++ | 1.7% | 0/10 | + | 1 |
25 | M | P | 50 | ++ | – | 3.8% | 0/10 | – | 1 |
26 | M | P | 30 | + | ++ | 1.6% | 1/10 | – | 1 |
27 | F | P | 16 | ++ | ++ | 2.5% | 1/10 | – | 36 |
28 | M | P | 31 | ++ | ++ | 2.7% | 1/10 | – | 2 |
29 | M | P | 17 | + | ++ | 1.2% | 0/10 | – | 0.5 |
30 | M | P | 20 | ++ | ++ | 2.2% | 1/10 | – | 0.5 |
31 | M | P | 31 | ++ | ++ | 2.3% | 1/10 | – | 0.5 |
32 | M | P | 20 | ++ | + | 0.8% | 1/10 | + | NA |
33 | F | P | 25 | ++ | + | 1.4% | 1/10 | + | 36 |
34 | F | P | 23 | ++ | ++ | 1.8% | 1/10 | – | 156 |
35 | M | P | 15 | + | + | 1.0% | 1/10 | + | 2 |